Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Baudax Bio, Inc. (BXRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.24 Metrics
OS: 6.97 M
Market cap: $1.69 M
Net cash: $1.42 M $0.20 per share
EV: $269.1 k

 
TTM Valuation
EBITDA ($55.4) M
EBIT ($52.9) M
EPS ($35.04)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues1.31.10.547.10.0
            Revenue growth17.5%119.1%-99.0%  
Cost of goods sold58.120.175.332.50.0
Gross profit-56.8-19.0-74.814.60.0
            Gross margin-4477.0%-1759.8%-15169.6%30.9% 
Selling, general and administrative0.00.00.027.0 
Research and development   20.135.6
General and administrative0.00.00.0 29.5
EBITA-58.8-18.0-57.2-32.5-73.5
            EBITA margin-4632.5%-1668.0%-11597.4%-69.1% 
Amortization of intangibles2.02.62.1  
EBIT-60.8-20.6-59.3-32.5-73.5
            EBIT margin-4789.9%-1906.5%-12032.7%-69.1% 
Pre-tax income-58.8-19.8-76.1-32.6-73.7
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income-58.8-19.8-76.1-32.6-73.7
            Net margin-4633.2%-1830.5%-15436.1%-69.2% 
 
Diluted EPS($177.30)($361.16)($142.87)($3.48)($7.88)
Shares outstanding (diluted)0.30.10.59.49.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy